Abstract
Genetic Engineering & Biotechnology NewsVol. 32, No. 21 TutorialMultiplexed Drug Assessment in 3DCombining Luminescence and Fluorescence Genetic Reporters to Assess Drug EffectsC. Oberdanner, Kevin Kopish, J. Stevenson, M. Salomon, M. Drewitz, and J.M. KelmC. OberdannerC. Oberdanner (E-mail Address: christian.oberdanner@tecan.com) is application scientist at Tecan Austria, Kevin Kopish is strategic marketing manager for cell analysis and J. Stevenson is general marketing manager at Promega, M. Salomon is vp development at Sirion Biotech, and M. Drewitz is senior research assistant and J.M. Kelm is co-founder and CSO at InSphero.Search for more papers by this author, Kevin KopishC. Oberdanner (E-mail Address: christian.oberdanner@tecan.com) is application scientist at Tecan Austria, Kevin Kopish is strategic marketing manager for cell analysis and J. Stevenson is general marketing manager at Promega, M. Salomon is vp development at Sirion Biotech, and M. Drewitz is senior research assistant and J.M. Kelm is co-founder and CSO at InSphero.Search for more papers by this author, J. StevensonC. Oberdanner (E-mail Address: christian.oberdanner@tecan.com) is application scientist at Tecan Austria, Kevin Kopish is strategic marketing manager for cell analysis and J. Stevenson is general marketing manager at Promega, M. Salomon is vp development at Sirion Biotech, and M. Drewitz is senior research assistant and J.M. Kelm is co-founder and CSO at InSphero.Search for more papers by this author, M. SalomonC. Oberdanner (E-mail Address: christian.oberdanner@tecan.com) is application scientist at Tecan Austria, Kevin Kopish is strategic marketing manager for cell analysis and J. Stevenson is general marketing manager at Promega, M. Salomon is vp development at Sirion Biotech, and M. Drewitz is senior research assistant and J.M. Kelm is co-founder and CSO at InSphero.Search for more papers by this author, M. DrewitzC. Oberdanner (E-mail Address: christian.oberdanner@tecan.com) is application scientist at Tecan Austria, Kevin Kopish is strategic marketing manager for cell analysis and J. Stevenson is general marketing manager at Promega, M. Salomon is vp development at Sirion Biotech, and M. Drewitz is senior research assistant and J.M. Kelm is co-founder and CSO at InSphero.Search for more papers by this author, and J.M. KelmSearch for more papers by this authorPublished Online:29 Nov 2012https://doi.org/10.1089/gen.32.21.10AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 32Issue 21Dec 2012 Information© 2012 by GEN PublishingTo cite this article:C. Oberdanner, Kevin Kopish, J. Stevenson, M. Salomon, M. Drewitz, and J.M. Kelm.Multiplexed Drug Assessment in 3D.Genetic Engineering & Biotechnology News.Dec 2012.22-23.http://doi.org/10.1089/gen.32.21.10Published in Volume: 32 Issue 21: November 29, 2012PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
